HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alain Hovnanian Selected Research
Alain Hovnanian Research Topics
Disease
32
Netherton Syndrome
02/2024 - 02/2002
18
Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
12/2023 - 09/2002
12
Inflammation (Inflammations)
02/2024 - 08/2007
10
Skin Diseases (Skin Disease)
02/2024 - 09/2007
8
Atopic Dermatitis (Atopic Eczema)
06/2024 - 05/2009
8
Darier Disease (Darier's Disease)
07/2014 - 09/2003
7
Genetic Skin Diseases
12/2016 - 10/2004
5
Hypersensitivity (Allergy)
10/2023 - 02/2008
4
Inborn Genetic Diseases (Disease, Hereditary)
01/2023 - 04/2010
4
Blister (Bulla)
01/2022 - 07/2003
4
Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2022 - 04/2006
4
Hidradenitis Suppurativa
10/2020 - 11/2015
4
Benign Familial Pemphigus (Hailey Hailey Disease)
02/2006 - 02/2002
3
Ichthyosis (Xeroderma)
10/2023 - 10/2010
3
Neoplasms (Cancer)
10/2023 - 01/2018
2
Rosacea (Acne Rosacea)
01/2023 - 08/2007
2
Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
03/2021 - 06/2016
2
Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
01/2020 - 01/2019
2
Erythema
01/2020 - 03/2010
2
Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
06/2017 - 10/2010
2
Exfoliative Dermatitis (Erythroderma)
03/2014 - 02/2002
2
Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2011 - 02/2008
2
Infections
09/2007 - 10/2006
2
Lamellar Ichthyosis (Harlequin Ichthyosis)
03/2007 - 07/2005
1
Arthralgia (Joint Pain)
10/2023
1
Diarrhea
10/2023
1
Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome)
01/2023
1
Dysbiosis
01/2023
1
Bullous Pemphigoid (Pemphigoid)
03/2021
1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
07/2020
1
Job Syndrome (Hyper-IgE Syndrome)
01/2020
1
Pain (Aches)
10/2019
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019
1
Epidermolysis Bullosa
01/2019
1
Squamous Cell Carcinoma of Head and Neck
01/2018
1
Virus Diseases (Viral Diseases)
10/2017
1
Wounds and Injuries (Trauma)
01/2016
1
Pyoderma Gangrenosum
11/2015
1
Acne Vulgaris
11/2015
1
Erythrokeratodermia Variabilis
06/2015
Drug/Important Bio-Agent (IBA)
17
Peptide Hydrolases (Proteases)
FDA Link
02/2024 - 01/2005
16
Collagen Type VII
IBA
01/2023 - 03/2006
14
Kallikreins (Kallikrein)
IBA
01/2023 - 05/2009
11
Proteins (Proteins, Gene)
FDA Link
12/2023 - 02/2002
11
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
01/2021 - 10/2003
9
Serine Peptidase Inhibitor Kazal-Type 5
IBA
02/2024 - 02/2002
6
Protease Inhibitors (Protease Inhibitor)
IBA
01/2022 - 07/2006
6
Adenosine Triphosphatases (ATPase)
IBA
02/2006 - 02/2002
5
Serine Proteases (Serine Protease)
IBA
01/2022 - 08/2007
4
Keratins (Keratin)
IBA
06/2017 - 12/2003
3
Cathelicidins
IBA
01/2023 - 10/2006
3
Immunoglobulin E (IgE)
IBA
01/2022 - 02/2002
3
Lipids
IBA
05/2014 - 07/2005
3
Thymic Stromal Lymphopoietin
IBA
03/2014 - 05/2009
3
Calcium
IBA
05/2011 - 12/2003
3
Calcium-Transporting ATPases (Ca2+ ATPase)
IBA
10/2006 - 09/2003
3
Protein Isoforms (Isoforms)
IBA
02/2006 - 09/2003
2
baricitinib
IBA
06/2024 - 10/2023
2
Cytokines
IBA
02/2024 - 02/2013
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2023 - 01/2020
2
Autoantibodies
IBA
03/2021 - 06/2016
2
Filaggrin Proteins
IBA
03/2014 - 03/2010
2
Trypsin
IBA
01/2013 - 07/2006
2
Keratin-14 (Keratin 14)
IBA
10/2011 - 04/2006
2
HLA-B Antigens (HLA-B)
IBA
07/2011 - 02/2008
2
pancreatic elastase II
IBA
08/2010 - 03/2010
2
Nevirapine (Viramune)
FDA Link
02/2008 - 02/2008
1
interleukin 20 (IL-20)
IBA
02/2024
1
Interleukin-17 (Interleukin 17)
IBA
02/2024
1
Ribonucleoproteins
IBA
12/2023
1
Histamine (Histamine Dihydrochloride)
FDA Link
10/2023
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
01/2022
1
Interferons
IBA
01/2022
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2022
1
ixekizumab
IBA
05/2021
1
Indoles
IBA
10/2020
1
Tryptophan (L-Tryptophan)
FDA Link
10/2020
1
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
10/2020
1
dupilumab
IBA
01/2020
1
staphylococcal delta toxin
IBA
01/2020
1
Sirolimus (Rapamycin)
FDA Link
01/2020
1
16S Ribosomal RNA
IBA
01/2020
1
secukinumab
IBA
01/2020
1
ON 01910
IBA
01/2019
1
Keratin-5 (Keratin 5)
IBA
01/2019
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
APOBEC Deaminases
IBA
01/2018
1
diacerein
IBA
01/2018
1
Antiviral Agents (Antivirals)
IBA
10/2017
1
Vaccines
IBA
10/2017
1
Antisense Oligoribonucleotides
IBA
12/2016
1
Ertapenem (Invanz)
FDA Link
02/2016
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2015
1
Connexins
IBA
06/2015
1
matriptase
IBA
01/2015
1
Allergens
IBA
10/2014
1
miglustat (Zavesca)
FDA Link
07/2014
1
Enzymes
IBA
06/2014
Therapy/Procedure
10
Therapeutics
01/2022 - 09/2002
1
Subcutaneous Injections
12/2016